Infant respiratory distress syndrome (RDS), sometimes referred to as neonatal RDS, is most common in babies born prematurely. When babies are born prematurely, their lungs may not be fully developed, ...

Infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves ...

New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed ...

Objective: The aim of the study was to measure pulmonary mechanics in infants with respiratory distress syndrome before extubation and to correlate pulmonary function values with successful extubation ...

Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...

Prenatal exposure to air pollution increases the risk of severe respiratory distress in newborn babies, according to new research. The risk increases with exposure specifically to fine particulate ...

HealthDay News — The FDA has approved Surfaxin (lucinactant) to prevent respiratory distress syndrome (RDS) in premature infants. Premature infants born before 37 weeks’ gestation often cannot produce ...

The most likely diagnosis for this infant is bronchiolitis. This illness is the most common reason for hospitalization of an infant or preschool-age child in the United States. [1] Bronchiolitis is ...

The innovation—a handheld dry powder inhaler for newborns in respiratory distress—recently cleared a proof-of-concept milestone, with results published in a peer-reviewed journal. Now, inventors ...

A baby's first breaths involve more than just getting air into the lungs, and for the first time research has identified the ...